Common Genetic Aspects Between COVID-19 and Sarcoidosis: A Network-based Approach Using Gene Expression Data

Overview

Journal Biochem Biophys Rep

Specialty Biochemistry

Date 2022 Feb 7

PMID 35128085

Authors

Md Roman Mogal

Sagarika Adhikary Sompa

Asadullah Junayed

Md Rashel Mahmod

Md Zainul Abedin

Md Asaduzzaman Sikder

Affiliations

Soon will be listed here.

Abstract

The pandemic situation of novel coronavirus disease 2019 (COVID-19) is a global threat on our current planet, with its rapid spread and high mortality rate. Sarcoidosis patients are at high risk to COVID-19 severity for having lung injuries as well as treating with immunosuppressive agents. So, physicians are in dilemma whether they should use immunosuppressive agents or not for the patients with sarcoidosis history and COVID-19 infection. Therefore, common factors should be identified to provide effective treatment. For determining the common genes between COVID-19 and sarcoidosis, GSE164805 and GSE18781 were retrieved from the Gene Expression Omnibus (GEO) database. Common upregulated genes were identified by using R language to investigate their involved pathways and gene ontologies (GO). With the aid of the STRING Cytoscape plugin tool, protein-protein interactions (PPIs) network was constructed. From the PPIs network, Hub genes and essential modules were detected by using Cytohubba, and MCODE respectively. For hub genes, TFs, TFs-miRNA, and drug, interaction networks were built through the NetworkAnalyst web platform. A total of 34 common upregulated genes were identified and among them, five hub genes, including TET2, MUC5AC, VDR, NFE2L2, and BCL6 were determined. In addition, a cluster having VDR and NFE2L2 was detected from the PPIs network. Moreover, 32 transcription factors and 9 miRNA were recognized for hub genes. Furthermore, vitamin D and some of its analogous compounds were obtained from the drug interaction network. In conclusion, hub genes identified in this study might have potential roles in modulating COVID-19 infection and sarcoidosis. However, further studies are required to corroborate this study.

Citing Articles

Integrated bioinformatics analysis reveals upregulated extracellular matrix hub genes in pancreatic cancer: Implications for diagnosis, prognosis, immune infiltration, and therapeutic strategies.

Mogal M, Jame J, Sohel M, Mozibullah M, Mahmod M, Junayed A Cancer Rep (Hoboken). 2024; 7(4):e2059.

PMID: 38639039 PMC: 11027013. DOI: 10.1002/cnr2.2059.

Incidence, management and prognosis of new-onset sarcoidosis post COVID-19 infection.

Vij O, Dey M, Morrison K, Kouranloo K Sarcoidosis Vasc Diffuse Lung Dis. 2024; 41(1):e2024004.

PMID: 38567560 PMC: 11008326. DOI: 10.36141/svdld.v41i1.15027.

References

Chaiboonchoe A, Samarasinghe S, Kulasiri D, Salehi-Ashtiani K . Integrated analysis of gene network in childhood leukemia from microarray and pathway databases. Biomed Res Int. 2014; 2014:278748. PMC: 4009339. DOI: 10.1155/2014/278748. View

Chen E, Tan C, Kou Y, Duan Q, Wang Z, Meirelles G . Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013; 14:128. PMC: 3637064. DOI: 10.1186/1471-2105-14-128. View

Mizumura K, Maruoka S, Shimizu T, Gon Y . Role of Nrf2 in the pathogenesis of respiratory diseases. Respir Investig. 2019; 58(1):28-35. DOI: 10.1016/j.resinv.2019.10.003. View

Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J . STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2014; 43(Database issue):D447-52. PMC: 4383874. DOI: 10.1093/nar/gku1003. View

Sundar I, Rahman I . Vitamin d and susceptibility of chronic lung diseases: role of epigenetics. Front Pharmacol. 2011; 2:50. PMC: 3171063. DOI: 10.3389/fphar.2011.00050. View

Mallapaty S . Can COVID vaccines stop transmission? Scientists race to find answers. Nature. 2021; . DOI: 10.1038/d41586-021-00450-z. View

Liu Z, Wu C, Miao H, Wu H . RegNetwork: an integrated database of transcriptional and post-transcriptional regulatory networks in human and mouse. Database (Oxford). 2015; 2015. PMC: 4589691. DOI: 10.1093/database/bav095. View

Zhu B, Zhang R, Li C, Jiang L, Xiang M, Ye Z . BCL6 modulates tissue neutrophil survival and exacerbates pulmonary inflammation following influenza virus infection. Proc Natl Acad Sci U S A. 2019; 116(24):11888-11893. PMC: 6575592. DOI: 10.1073/pnas.1902310116. View

Sweiss N, Korsten P, Syed H, Syed A, Baughman R, Yee A . When the Game Changes: Guidance to Adjust Sarcoidosis Management During the Coronavirus Disease 2019 Pandemic. Chest. 2020; 158(3):892-895. PMC: 7189863. DOI: 10.1016/j.chest.2020.04.033. View

10.

Dureault A, Chapelon C, Biard L, Domont F, Savey L, Bodaghi B . Severe infections in sarcoidosis: Incidence, predictors and long-term outcome in a cohort of 585 patients. Medicine (Baltimore). 2017; 96(49):e8846. PMC: 5728866. DOI: 10.1097/MD.0000000000008846. View

11.

Kim B, Arany Z . Editorial commentary: Could shear stress mimetics delay complications in COVID-19?. Trends Cardiovasc Med. 2021; 32(2):71-72. PMC: 7838584. DOI: 10.1016/j.tcm.2021.01.004. View

12.

Pfeffer P, Hawrylowicz C . Vitamin D and lung disease. Thorax. 2012; 67(11):1018-20. DOI: 10.1136/thoraxjnl-2012-202139. View

13.

Li J, Ye Z . The Potential Role and Regulatory Mechanisms of MUC5AC in Chronic Obstructive Pulmonary Disease. Molecules. 2020; 25(19). PMC: 7582261. DOI: 10.3390/molecules25194437. View

14.

Yisak H, Ewunetei A, Kefale B, Mamuye M, Teshome F, Ambaw B . Effects of Vitamin D on COVID-19 Infection and Prognosis: A Systematic Review. Risk Manag Healthc Policy. 2021; 14:31-38. PMC: 7800698. DOI: 10.2147/RMHP.S291584. View

15.

Zhou G, Soufan O, Ewald J, Hancock R, Basu N, Xia J . NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res. 2019; 47(W1):W234-W241. PMC: 6602507. DOI: 10.1093/nar/gkz240. View

16.

Wilkinson A, Nakauchi H, Gottgens B . Mammalian Transcription Factor Networks: Recent Advances in Interrogating Biological Complexity. Cell Syst. 2017; 5(4):319-331. PMC: 5928788. DOI: 10.1016/j.cels.2017.07.004. View

17.

Manansala M, Ascoli C, Alburquerque A, Perkins D, Mirsaedi M, Finn P . Case Series: COVID-19 in African American Patients With Sarcoidosis. Front Med (Lausanne). 2020; 7:588527. PMC: 7672207. DOI: 10.3389/fmed.2020.588527. View

18.

Chen E, Moller D . Etiologies of Sarcoidosis. Clin Rev Allergy Immunol. 2015; 49(1):6-18. DOI: 10.1007/s12016-015-8481-z. View

19.

Ghosh A, Moll M, Hayden L, Bon J, Regan E, Hersh C . Vitamin D deficiency is associated with respiratory symptoms and airway wall thickening in smokers with and without COPD: a prospective cohort study. BMC Pulm Med. 2020; 20(1):123. PMC: 7199369. DOI: 10.1186/s12890-020-1148-4. View

20.

Gyorfi A, Kopp M, May M, Vetter M, Uder M, Kremer A . Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis. Ann Rheum Dis. 2020; 80(6):e87. DOI: 10.1136/annrheumdis-2020-218258. View